The U.S. Food and Drug Administration (FDA) last year approved of ultrasound and radiofrequency ablation-based renal denervation devices that can be used to “reduce blood pressure as an adjunctive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback